Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance

Junhua Lyu; Yuxuan Liu; Lihu Gong; Mingyi Chen; Yazan F. Madanat; Yuannyu Zhang; Feng Cai; Zhimin Gu; Hui Cao; Pranita Kaphle; Yoon Jung Kim; Fatma N. Kalkan; Helen Stephens; Kathryn E. Dickerson; Min Ni; Weina Chen; Prapti A. Patel; Alice S. Mims; Uma Borate; Amy Burd; Sheng F. Cai; C. Cameron Yin; M. James You; Stephen S. Chung; Robert H. Collins; Ralph J. DeBerardinis; Xin Liu; Jian Xu

doi:10.1158/2159-8290.30848992

Abstract

Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance

Related Publications

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

Cory M. Johannessen , Jesse S. Boehm , So Young Kim +32 more

Oncogenic mutations in the serine/threonine kinase B-RAF (also known as BRAF) are found in 50–70% of malignant melanomas. Pre-clinical studies have demonstrated that the B-RAF(V...

2010 Nature 1436 citations

Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma

Mohammad Atefi , Earl Avramis , Amanda Lassen +9 more

Abstract Purpose: PD-L1 is the main ligand for the immune inhibitory receptor PD-1. This ligand is frequently expressed by melanoma cells. In this study, we investigated whether...

2014 Clinical Cancer Research 323 citations

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Ramin Nazarian , Hubing Shi , Qi Wang +13 more

Activating B-RAF(V600E) (also known as BRAF) kinase mutations occur in ∼7% of human malignancies and ∼60% of melanomas. Early clinical experience with a novel clas...

2010 Nature 2132 citations

Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with <i>EGFR</i>-Mutant Lung Adenocarcinoma

James Bean , Gregory J. Riely , Marissa N. Balak +4 more

Abstract Purpose: Somatic mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene are associated with sensitivity of lung adenocarcinomas to ...

2008 Clinical Cancer Research 276 citations

Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling

Nikhil Wagle , W. Marston Linehan , Michael F. Berger +9 more

A detailed understanding of the mechanisms by which tumors acquire resistance to targeted anticancer agents should speed the development of treatment strategies with lasting cli...

2011 Journal of Clinical Oncology 988 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

CrossRef

Cite This

APA Style

                            
                                    Junhua Lyu, 
                                
                                    Yuxuan Liu, 
                                
                                    Lihu Gong
                                
                                et al.
                            
                            (2025). 
                            Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance. 
                            
                            .
                            https://doi.org/10.1158/2159-8290.30848992

Identifiers

DOI: 10.1158/2159-8290.30848992

Data Quality

Data completeness: 66%